These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia. Christensen SB; Hone AJ; Roux I; Kniazeff J; Pin JP; Upert G; Servent D; Glowatzki E; McIntosh JM Front Cell Neurosci; 2017; 11():219. PubMed ID: 28785206 [TBL] [Abstract][Full Text] [Related]
4. Nicotinic Acetylcholine Receptors Mediate the Suppressive Effect of an Injection of Diluted Bee Venom into the GV3 Acupoint on Oxaliplatin-Induced Neuropathic Cold Allodynia in Rats. Yoon H; Kim MJ; Yoon I; Li DX; Bae H; Kim SK Biol Pharm Bull; 2015; 38(5):710-4. PubMed ID: 25752933 [TBL] [Abstract][Full Text] [Related]
5. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management? Mohammadi SA; Christie MJ Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047 [TBL] [Abstract][Full Text] [Related]
6. RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats. Huynh PN; Giuvelis D; Christensen S; Tucker KL; McIntosh JM Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31877728 [TBL] [Abstract][Full Text] [Related]
7. α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia. Mohammadi S; Christie MJ Mol Pain; 2014 Oct; 10():64. PubMed ID: 25274008 [TBL] [Abstract][Full Text] [Related]
8. Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain. Zheng N; Christensen SB; Dowell C; Purushottam L; Skalicky JJ; McIntosh JM; Chou DH J Med Chem; 2021 Jul; 64(13):9513-9524. PubMed ID: 34161094 [TBL] [Abstract][Full Text] [Related]
9. From Crystal Structures of RgIA4 in Complex with Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708 [TBL] [Abstract][Full Text] [Related]
10. The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic. Holtman JR; Dwoskin LP; Dowell C; Wala EP; Zhang Z; Crooks PA; McIntosh JM Eur J Pharmacol; 2011 Nov; 670(2-3):500-8. PubMed ID: 21944926 [TBL] [Abstract][Full Text] [Related]
11. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain. Wang H; Li X; Zhangsun D; Yu G; Su R; Luo S Mar Drugs; 2019 May; 17(5):. PubMed ID: 31060282 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors. Vincler M; Wittenauer S; Parker R; Ellison M; Olivera BM; McIntosh JM Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17880-4. PubMed ID: 17101979 [TBL] [Abstract][Full Text] [Related]
13. α9-containing nicotinic acetylcholine receptors and the modulation of pain. Hone AJ; Servent D; McIntosh JM Br J Pharmacol; 2018 Jun; 175(11):1915-1927. PubMed ID: 28662295 [TBL] [Abstract][Full Text] [Related]
14. Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and Ca Arias HR; Tae HS; Micheli L; Yousuf A; Ghelardini C; Adams DJ; Di Cesare Mannelli L Neuropharmacology; 2020 Sep; 175():108194. PubMed ID: 32540451 [TBL] [Abstract][Full Text] [Related]
15. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain. Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895 [TBL] [Abstract][Full Text] [Related]
16. Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats. Wala EP; Crooks PA; McIntosh JM; Holtman JR Anesth Analg; 2012 Sep; 115(3):713-20. PubMed ID: 22610850 [TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain. Klimis H; Adams DJ; Callaghan B; Nevin S; Alewood PF; Vaughan CW; Mozar CA; Christie MJ Pain; 2011 Feb; 152(2):259-266. PubMed ID: 20889259 [TBL] [Abstract][Full Text] [Related]
18. Alpha9 nicotinic acetylcholine receptors and the treatment of pain. McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168 [TBL] [Abstract][Full Text] [Related]
20. N-Terminal Capping of the αO-Conotoxin Analogue GeX-2 Improves the Serum Stability and Selectivity toward the Human α9α10 Nicotinic Acetylcholine Receptor. Li X; Zhou S; Tae HS; Wang S; Li T; Cai W; Jiang T; Adams DJ; Yu R J Med Chem; 2024 Oct; 67(20):18400-18411. PubMed ID: 39361522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]